Peter Anevski - 02 Mar 2026 Form 4 Insider Report for Progyny, Inc. (PGNY)

Reporting relationship: CHIEF EXECUTIVE OFFICER, Director
Issuer ticker: PGNY
Reported as of: 02 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Mar 2026, 17:30:50 UTC
Prior SEC filing: 05 Jan 2026
Next SEC filing: 05 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Mark Livingston, Attorney-in-Fact

Key filing fact

Peter Anevski filed Form 4 for Progyny, Inc. (PGNY) on 04 Mar 2026.

Key facts

This page summarizes Peter Anevski's Form 4 filing for Progyny, Inc. (PGNY).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 04 Mar 2026, 17:30.

Change

Previous filing in this sequence was filed on 05 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001576147 Primary reporting owner

Anevski Peter

Relationship: CHIEF EXECUTIVE OFFICER, Director
Address: C/O PROGYNY, INC., 1359 BROADWAY, 2ND FLOOR, NEW YORK
Signature: /s/ Mark Livingston, Attorney-in-Fact
Signature date: 04 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PGNY transaction

Common Stock

Award

Transaction value
Shares: +159,091
Change %: +24%
Price: $0.000000^*
Shares after: 834,444
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F1, F2

PGNY transaction

Common Stock

Tax liability

Transaction value
Shares: -17,611
Change %: -2.1%
Price: $17.60^*
Shares after: 816,833
Date: 03 Mar 2026
Ownership: Direct
Footnotes: F3

PGNY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1
Date: 02 Mar 2026
Ownership: See footnote
Footnotes: F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PGNY transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +232,011
Change %
Price: $0.000000^*
Shares after: 232,011
Date: 02 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 232,011
Exercise price: $17.60
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). This was an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. 33% of the RSUs will vest on the first anniversary of the grant date, with the remainder vesting quarterly in installments thereafter through the third anniversary of the grant date, subject to the Reporting Person's continued service on each applicable vesting date.

Footnote F2

Includes 1,111 shares acquired under the Issuer's 2019 Employee Stock Purchase Plan on January 30, 2026.

Footnote F3

Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.

Footnote F4

The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC.

Footnote F5

Represents an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. 33% of the shares will vest on the first anniversary of the grant date, with the remainder vesting quarterly in installments thereafter through the third anniversary of the grant date, subject to the Reporting Person's continued service on each applicable vesting date.